Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids

被引:104
作者
Bates, RC
Goldsmith, JD
Bachelder, RE
Brown, C
Shibuya, M
Oettgen, P
Mercurio, AM
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA 02215 USA
[4] Univ Tokyo, Inst Med Sci, Dept Genet, Tokyo 1088639, Japan
关键词
D O I
10.1016/j.cub.2003.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant cell survival and resistance to apoptosis are hallmarks of tumor invasion and progression to metastatic disease [1], but the mechanisms involved are poorly understood. The epithelial-mesenchymal transition (EMT), a process that facilitates progression to invasive cancer, provides a superb model for studying such survival mechanisms. Here, we used a unique spheroid culture system that recapitulates the structure of the colonic epithelium and undergoes an EMT in response to cytokine stimulation to study this problem [2]. Our data reveal that the EMT results in the increased expression of both VEGF and Flt-1, a tyrosine kinase VEGF receptor, and that the survival of these cells depends on a VEGF/Flt-1 autocrine pathway. Perturbation of Flt-1 function by either a blocking antibody or adenoviral expression of soluble Flt-1, which acts in a dominant-negative fashion, caused massive apoptosis only in cells that underwent EMT. This pathway was critical for the survival of other invasive colon carcinoma cell lines, and we observed a correlative upregulation of Flt-1 expression linked to in vivo human cancer progression. A role for Flt-1 in cell survival is unprecedented and has significant implications for Flt-1 function in tumor progression, as well as in other biological processes, including angiogenesis and development.
引用
收藏
页码:1721 / 1727
页数:7
相关论文
共 37 条
[21]  
Mahasreshti PJ, 2001, CLIN CANCER RES, V7, P2057
[22]   Therapies directed at vascular endothelial growth factor [J].
Manley, PW ;
Martiny-Baron, G ;
Schlaeppi, JM ;
Wood, JM .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (12) :1715-1736
[23]   TGF-beta 1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells [J].
Oft, M ;
Peli, J ;
Rudaz, C ;
Schwarz, H ;
Beug, H ;
Reichmann, E .
GENES & DEVELOPMENT, 1996, 10 (19) :2462-2477
[24]   TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis [J].
Oft, M ;
Heider, KH ;
Beug, H .
CURRENT BIOLOGY, 1998, 8 (23) :1243-1252
[25]  
PARK JE, 1994, J BIOL CHEM, V269, P25646
[26]   Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition [J].
Savagner, P .
BIOESSAYS, 2001, 23 (10) :912-923
[27]   Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans [J].
Sawano, A ;
Iwai, S ;
Sakurai, Y ;
Ito, M ;
Shitara, K ;
Nakahata, T ;
Shibuya, M .
BLOOD, 2001, 97 (03) :785-791
[28]   Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype [J].
Soker, S ;
Kaefer, M ;
Johnson, M ;
Klagsbrun, M ;
Atala, A ;
Freeman, MR .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :651-659
[29]   Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma [J].
Strizzi, L ;
Catalano, A ;
Vianale, G ;
Orecchia, S ;
Casalini, A ;
Tassi, G ;
Puntoni, R ;
Mutti, L ;
Procopio, A .
JOURNAL OF PATHOLOGY, 2001, 193 (04) :468-475
[30]  
Takayama K, 2000, CANCER RES, V60, P2169